MedTrace Logo

Efficacy of Glutamine in Management of Radiation Mucositis

NCT05856188 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-05-12

No results posted yet for this study

Summary

The goal of this \[ type of study: Clinical trial\] is to test effectiveness of glutamine in management of Radiation Induced Mucositis in head and neck cancer patients.

The main question \[s\] \] is to \[ learn about, test, compare etc.\] it aims to answer are:

1. Is glutamine effective in management of Radiation Induced Mucositis?
2. Does Glutamine oral suspension affect the level of TGFβ1 in saliva of patients with radiation induced mucositis? participants will be asked to dissolve oral glutamine and maltodextrin in distalled water and swish and swallow three times daily during radiotherapy.

Conditions

  • Radiation-Induced Mucositis

Interventions

DIETARY_SUPPLEMENT

Glutamine

Biologic

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Suzan SA Ibrahim, professor · faculty of Dentistry- Ainshams university

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-06-01
Completion
2023-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05856188 on ClinicalTrials.gov